Trials / Sponsors / Ahmad Tarhini
Ahmad Tarhini
Academic / Other · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Phase II Study of High Dose Bolus IL2 in Patients With Inoperable Stage III or Stage IV Melanoma Who Have Fa Melanoma | Phase 2 | 2016-09-01 |
| Completed | AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | 2011-08-01 |
| Terminated | Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer Small Cell Lung Cancer | Phase 1 | 2009-09-01 |
| Completed | Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by S Intraocular Melanoma, Malignant Conjunctival Neoplasm, Melanoma (Skin) | Phase 1 | 2008-10-01 |
| Completed | Safety and Efficacy of Combination HDI and Anti-CTLA4 for Recurrent Inoperable Stage III or Stage IV Melanoma Melanoma | Phase 2 | 2006-11-01 |
| Completed | Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer Small Cell Lung Cancer | Phase 2 | 2006-10-01 |